has received a minority investment from
Cascadia Capital, an investment bank serving middle market clients globally, today announced it acted as the exclusive financial advisor to SonoSim, a global leader in ultrasound education and training, in securing a minority investment from GE Healthcare.
Founded in 2012 and currently collaborating with over 400 medical institutions globally, SonoSim offers the industry’s most extensive ultrasound training platform with over 60 medical topics providing cloud-based courses, interactive scanning of virtual patients, and performance tracking. Named by Inc. Magazine once again in 2018 as one of the fastest-growing private companies in the nation, SonoSim is now one of the top five fastest-growing education companies in Los Angeles.
The partnership with GE Healthcare will offer enhanced education services to new and existing ultrasound users across medical disciplines by overcoming the traditional barriers that have limited successful integration of ultrasound into daily clinical practice. The pairing of SonoSim’s education and training offerings with GE Healthcare’s ultrasound technology will enable seamless integration of ultrasound into clinical practice and improved patient care.
“We approached Cascadia to help us develop a strategy to finance SonoSim’s rapid growth,” said Koren Bertolli, Chief Operating Officer, SonoSim, Inc. “Their ability to execute the plan and attract a large strategic partner for our business is where the Cascadia team showed their best-in-class pedigree.”
“The SonoSim team recognized the opportunity to supercharge an already fast-growing business,” said Kevin Cable, Managing Director with Cascadia Capital. “GE was the perfect partner to help them realize their vision both nationally and internationally.”
Advising SonoSim represents another successful transaction for Cascadia’s Healthcare & Digital Health investment banking team. Recent transactions include the financings of Vera Whole Health, BardyDX and Impel Neuropharma, and the acquisition of DatStat.